Managers / Q3 2025 · view latest →
Harold Davidson & Associates Inc.
CIK 0001430022 · 1801 CENTURY PARK EAST, SUITE 2150, LOS ANGELES, CA, 90067 · 310-553-5551
Summary
Harold Davidson & Associates Inc. reported $220M in U.S.-listed holdings across 65 positions for Q3 2025.
The portfolio is heavily concentrated: AAPL alone accounts for 23.6% of reported value.
Compared with Q2 2025, the fund opened 6 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.9% · $218M
- Other · 0.8% · $2M
- ETP · 0.4% · $874,486
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HOODROBINHOOD MKTS INC | NEW | +11.7K | 11.7K | +$2M | $2M |
| KTOSKRATOS DEFENSE & SEC SOLUTIO | NEW | +17.4K | 17.4K | +$2M | $2M |
| IBMINTERNATIONAL BUSINESS MACHS | NEW | +1.5K | 1.5K | +$434,526 | $434,526 |
| SPDR S&P 500 ETF TR | NEW | +488 | 488 | +$324,957 | $324,957 |
| JOBY AVIATION INC | NEW | +18.7K | 18.7K | +$302,109 | $302,109 |
| ISHARES TR | NEW | +3.9K | 3.9K | +$208,527 | $208,527 |
| GEVGE VERNOVA INC | ADDED | +1.9K | 2.3K | +$1M | $1M |
| ALLOALLOGENE THERAPEUTICS INC | ADDED | +160.2K | 295.4K | +$213,528 | $366,336 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.